Rxivist logo

Quantifying Immune-Based Counterselection of Somatic Mutations

By Fan Yang, Dae-Kyum Kim, Hidewaki Nakagawa, Shuto Hayashi, Seiya Imoto, Lincoln D. Stein, Frederick P. Roth

Posted 14 Nov 2017
bioRxiv DOI: 10.1101/219576 (published DOI: 10.1371/journal.pgen.1008227)

It is now well established that somatic mutations in protein-coding regions can generate neoantigens, and that these can be recognized by the immune system and contribute to clearance of developing cancers. However, there is currently no model that can quantitatively predict the neoantigenic effect of any given somatic mutation. Here, we examined signatures of immune selection pressure on the distribution of somatic mutations. We quantified the extent to which somatic mutations are significantly depleted in peptides that are predicted to be displayed by major histocompatibility complex (MHC) class I proteins. We characterized the dependence of this depletion on expression level. We then examined whether immune selection pressure on somatic mutations changes depending on whether the patient had either one or two MHC-encoding alleles that can display the peptide. Our results indicate that MHC-encoding alleles are, in general, incompletely dominant, i.e., that having two copies of the display-enabling allele is more effective in displaying that peptide than having just one copy. More generally, a quantitative understanding of counter-selection of identifiable subclasses of neoantigenic somatic variation could guide immunotherapy or aid in developing personalized cancer vaccines.

Download data

  • Downloaded 741 times
  • Download rankings, all-time:
    • Site-wide: 40,423
    • In genetics: 1,780
  • Year to date:
    • Site-wide: 146,439
  • Since beginning of last month:
    • Site-wide: 153,412

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide